Ellen Lubman
Investor Relations Contact at WEREWOLF THERAPEUTICS, INC.
Net worth: - $ as of 2024-06-29
Ellen Lubman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Investor Relations Contact | 2020-07-31 | - |
| Corporate Officer/Principal | 2020-07-31 | - | |
GeneCentric Therapeutics, Inc.
 GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Director/Board Member | - | - |
Gilda's Club New York City, Inc.
 Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Gilda's Club New York City, Inc. provides support services to cancer patients. Its programs include cancer support for all, offsite program, and programs for children and teens with cancer. The company was founded by Gene Wilder, Joanna Bull, Mandy Patinkin, and Joel Siegel in 1995 and is headquartered in New York, NY. | Director/Board Member | - | - |
Intrepida Bio, Inc.
 Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Intrepida Bio, Inc. discovers and develops medicines to modulate the innate immune system to fight cancer and other diseases. The company was founded by Joel F. Martin and Olivier Laurent and is headquartered in San Diego, CA. | Director/Board Member | - | - |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on September 30, 2008 and is headquartered in Toronto, Canada. | Director/Board Member | 2021-05-31 | - |
| Independent Dir/Board Member | 2021-05-31 | - |
Career history of Ellen Lubman
Former positions of Ellen Lubman
| Companies | Position | Start | End |
|---|---|---|---|
| IPI LEGACY LIQUIDATION CO | Corporate Officer/Principal | 2018-09-30 | 2020-06-30 |
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | 2014-01-31 | 2014-06-30 |
Celtic Pharma Management LP
 Celtic Pharma Management LP Investment ManagersFinance Celtic Pharma Management LP is a private equity firm founded by Stephen Evans Freke and John Mayo in 2004. The firm headquartered in Bermuda. | Corporate Officer/Principal | - | 2008-10-31 |
| REUNION NEUROSCIENCE | Director/Board Member | 2021-06-06 | - |
Training of Ellen Lubman
| Stanford University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Statistics
International
| United States | 9 |
| Canada | 3 |
| Bermuda | 2 |
Operational
| Director/Board Member | 5 |
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| WEREWOLF THERAPEUTICS, INC. | Health Technology |
| IPI LEGACY LIQUIDATION CO | Health Technology |
 | Health Technology |
| Private companies | 6 |
|---|---|
Celtic Pharma Management LP
Celtic Pharma Management LP Investment ManagersFinance Celtic Pharma Management LP is a private equity firm founded by Stephen Evans Freke and John Mayo in 2004. The firm headquartered in Bermuda. | Finance |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Health Technology |
Gilda's Club New York City, Inc.
Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Gilda's Club New York City, Inc. provides support services to cancer patients. Its programs include cancer support for all, offsite program, and programs for children and teens with cancer. The company was founded by Gene Wilder, Joanna Bull, Mandy Patinkin, and Joel Siegel in 1995 and is headquartered in New York, NY. | Commercial Services |
Intrepida Bio, Inc.
Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Intrepida Bio, Inc. discovers and develops medicines to modulate the innate immune system to fight cancer and other diseases. The company was founded by Joel F. Martin and Olivier Laurent and is headquartered in San Diego, CA. | Health Technology |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Field Trip Health Ltd.
 Field Trip Health Ltd. Medical/Nursing ServicesHealth Services Field Trip Health Ltd. engages in development and delivery of technology-enabled psychedelic therapies. It offers psychedelic-enhanced and psychedelic-integration psychotherapy. The firm is developing patient-centric and evidence-based psychedelic approaches to behavioral and mental health. The company was founded by Joseph del Moral, Ronan Levy, Hannan Fleiman, Syed Mujeeb Jafferi, and Ryan Yermus on September 30, 2008 and is headquartered in Toronto, Canada. | Health Services |
- Stock Market
- Insiders
- Ellen Lubman
- Experience
